Stempoint Capital’s KalVista Pharmaceuticals KALV Stock Holding History

Stempoint Capital’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$691K	Sell
2025 Q2	$4.37M	Sell
2025 Q1	$4.46M	Sell
2024 Q4	$8.41M	Buy
2024 Q3	–	Sell
2024 Q2	$8.68M	Sell
2024 Q1	$13.8M	Buy
2023 Q4	$5.18M	Buy